Effectiveness and safety of radiotherapy plus programmed death-1 inhibitors and lenvatinib in patients with advanced biliary tract carcinoma: a real-world study

Wang, YC; Yang, XB; Wang, YY; Xue, JN; Zhang, N; Yang, X; Cong, N; Zhang, JW; Zhu, CP; Zhang, LH; Hou, XR; Zhao, HT

Zhao, HT (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll CAMS, Peking Union Med Coll Hosp, Dept Liver Surg, 1, Shuaifuyuan, Beijing, Peoples R China.;Hou, XR (通讯作者)，Chinese Acad Med Sci & Peking Union Med Coll CAMS, Peking Union Med Coll Hosp, Dept Radiat Oncol, 1, Shuaifuyuan, Beijing, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023; 72 (7): 2197

Abstract

BackgroundRadiotherapy (RT) may function synergistically with immunotherapy and targeted agents (TA). This study aimed to assess the effectiveness and......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索